GEA
PFE icon

Glen Eagle Advisors’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$616K Buy
25,399
+730
+3% +$17.7K 0.09% 134
2025
Q1
$625K Sell
24,669
-5,193
-17% -$132K 0.1% 129
2024
Q4
$792K Buy
29,862
+5,796
+24% +$154K 0.13% 110
2024
Q3
$696K Sell
24,066
-2,902
-11% -$84K 0.12% 120
2024
Q2
$755K Sell
26,968
-10,979
-29% -$307K 0.14% 108
2024
Q1
$1.05M Sell
37,947
-5,260
-12% -$146K 0.2% 94
2023
Q4
$1.24M Sell
43,207
-7,777
-15% -$224K 0.26% 80
2023
Q3
$1.69M Sell
50,984
-273
-0.5% -$9.06K 0.39% 55
2023
Q2
$1.88M Buy
51,257
+5,198
+11% +$191K 0.43% 53
2023
Q1
$1.88M Buy
46,059
+2,547
+6% +$104K 0.47% 49
2022
Q4
$2.23M Sell
43,512
-441
-1% -$22.6K 0.61% 38
2022
Q3
$1.92M Sell
43,953
-8,634
-16% -$378K 0.56% 41
2022
Q2
$2.76M Buy
52,587
+5,514
+12% +$289K 0.75% 35
2022
Q1
$2.44M Sell
47,073
-99
-0.2% -$5.13K 0.64% 39
2021
Q4
$2.79M Sell
47,172
-1,641
-3% -$96.9K 0.72% 34
2021
Q3
$2.1M Buy
48,813
+2,736
+6% +$118K 0.61% 40
2021
Q2
$1.8M Buy
46,077
+1,080
+2% +$42.3K 0.56% 44
2021
Q1
$1.64M Buy
44,997
+2,825
+7% +$103K 0.57% 40
2020
Q4
$1.55M Buy
42,172
+523
+1% +$19.3K 0.61% 40
2020
Q3
$1.53M Buy
41,649
+4,763
+13% +$175K 0.68% 35
2020
Q2
$1.21M Buy
36,886
+19,615
+114% +$641K 0.62% 38
2020
Q1
$564K Buy
17,271
+4,010
+30% +$131K 0.4% 58
2019
Q4
$520K Buy
13,261
+2,276
+21% +$89.2K 0.28% 83
2019
Q3
$395K Buy
10,985
+193
+2% +$6.93K 0.26% 87
2019
Q2
$468K Buy
10,792
+86
+0.8% +$3.73K 0.32% 76
2019
Q1
$455K Buy
10,706
+621
+6% +$26.4K 0.33% 74
2018
Q4
$440K Buy
10,085
+182
+2% +$7.95K 0.37% 65
2018
Q3
$436K Sell
9,903
-150
-1% -$6.61K 0.31% 75
2018
Q2
$365K Buy
10,053
+1,531
+18% +$55.5K 0.29% 80
2018
Q1
$302K Buy
8,522
+807
+10% +$28.6K 0.25% 91
2017
Q4
$279K Buy
7,715
+415
+6% +$15K 0.24% 98
2017
Q3
$261K Sell
7,300
-2,119
-22% -$75.6K 0.24% 100
2017
Q2
$316K Buy
9,419
+180
+2% +$6.05K 0.25% 100
2017
Q1
$317K Sell
9,239
-222
-2% -$7.61K 0.27% 95
2016
Q4
$307K Buy
+9,461
New +$307K 0.28% 96